Physiology of the lung in idiopathic pulmonary fibrosis
暂无分享,去创建一个
Aurélie Cazes | Sylvain Marchand-Adam | A. Cazes | L. Plantier | B. Crestani | A. Dinh-Xuan | S. Marchand-Adam | C. Bancal | Bruno Crestani | Anh-Tuan Dinh-Xuan | Laurent Plantier | Catherine Bancal
[1] S. Rosselot. Idiopathic pulmonary fibrosis. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).
[2] J E Cotes,et al. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. , 1993, The European respiratory journal. Supplement.
[3] D. Johnson,et al. Importance of adjusting carbon monoxide diffusing capacity (DLCO) and carbon monoxide transfer coefficient (KCO) for alveolar volume. , 2000, Respiratory medicine.
[4] J. Milic-Emili,et al. The pattern of breathing in diffuse lung fibrosis. , 1982, Bulletin europeen de physiopathologie respiratoire.
[5] L. Plantier,et al. Cross-Sectional Assessment of the Relationships between Dyspnea Domains and Lung Function in Diffuse Parenchymal Lung Disease , 2013, Respiration.
[6] V. Melenovský,et al. Lung congestion in chronic heart failure: haemodynamic, clinical, and prognostic implications , 2015, European journal of heart failure.
[7] R. D. du Bois,et al. Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis , 2016, Thorax.
[8] A. Alavi,et al. Scintigraphic diagnosis of a right to left shunt in end-stage lung disease. , 2003, Respiratory medicine.
[9] V. Brusasco,et al. Lung diffusing capacity for nitric oxide as a marker of fibrotic changes in idiopathic interstitial pneumonias , 2016 .
[10] P. Calverley,et al. Cryptogenic fibrosing alveolitis with preserved lung volumes. , 1997, Thorax.
[11] P. Spagnolo,et al. Genetics of idiopathic pulmonary fibrosis: from mechanistic pathways to personalised medicine , 2016, Journal of Medical Genetics.
[12] J. Neder,et al. Common Mechanisms of Dyspnea in Chronic Interstitial and Obstructive Lung Disorders. , 2016, American journal of respiratory and critical care medicine.
[13] H. Collard,et al. A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis. , 2010, The New England journal of medicine.
[14] K. McCarthy,et al. Impact of pulmonary hemodynamics on 6-min walk test in idiopathic pulmonary fibrosis. , 2012, Respiratory Medicine.
[15] V. Poletti,et al. Abnormal Re-epithelialization and Lung Remodeling in Idiopathic Pulmonary Fibrosis: The Role of ΔN-p63 , 2002, Laboratory Investigation.
[16] C. Carvalho,et al. Effects of proportional assisted ventilation on exercise performance in idiopathic pulmonary fibrosis patients. , 2010, Respiratory medicine.
[17] Bruce D. Johnson,et al. Impaired Pulmonary Diffusion in Heart Failure With Preserved Ejection Fraction. , 2016, JACC. Heart failure.
[18] J. Holmes,et al. Echocardiographic and hemodynamic predictors of mortality in idiopathic pulmonary fibrosis. , 2013, Chest.
[19] T. Honda,et al. Pulmonary function impairment in patients with combined pulmonary fibrosis and emphysema with and without airflow obstruction , 2014, International journal of chronic obstructive pulmonary disease.
[20] O. Nishiyama,et al. Effect of ambulatory oxygen on exertional dyspnea in IPF patients without resting hypoxemia. , 2013, Respiratory medicine.
[21] W. Seeger,et al. Altered fatty acid composition of lung surfactant phospholipids in interstitial lung disease. , 2002, American journal of physiology. Lung cellular and molecular physiology.
[22] W. C. Miller,et al. Anatomical lung shunting in pulmonary fibrosis. , 1986, Thorax.
[23] P. Lansdorp,et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. , 2007, The New England journal of medicine.
[24] S. Miriuka,et al. Prediction of severe cardiovascular events by VE/VCO2 slope versus peak VO2 in systolic heart failure: a meta-analysis of the published literature. , 2010, American Heart Journal.
[25] D. Lockwood,et al. DLCO/Q and diffusion limitation at rest and on exercise in patients with interstitial fibrosis. , 1991, Respiration physiology.
[26] H. Collard,et al. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. , 2011, American journal of respiratory and critical care medicine.
[27] P. Filardi,et al. Exercise testing in the clinical management of patients affected by pulmonary arterial hypertension , 2012, European journal of preventive cardiology.
[28] Kevin Flaherty,et al. Pulmonary function testing in idiopathic interstitial pneumonias. , 2006, Proceedings of the American Thoracic Society.
[29] L. Stevenson,et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial , 2011, The Lancet.
[30] C. Roussos,et al. MRC chronic Dyspnea Scale: Relationships with cardiopulmonary exercise testing and 6-minute walk test in idiopathic pulmonary fibrosis patients: a prospective study , 2010, BMC pulmonary medicine.
[31] L. Forkert,et al. Idiopathic pulmonary fibrosis: new insights on functional characteristics at diagnosis. , 2014, Canadian respiratory journal.
[32] P. Vaida,et al. Determination of lung capillary blood volume and membrane diffusing capacity in man by the measurements of NO and CO transfer. , 1987, Respiration physiology.
[33] P. O'Byrne,et al. Is nedocromil sodium effective treatment for asthma? , 1993, The European respiratory journal.
[34] S. Nathan,et al. Predicting Life Expectancy for Pirfenidone in Idiopathic Pulmonary Fibrosis. , 2017, Journal of managed care & specialty pharmacy.
[35] A. Nicholson,et al. Interstitial vascularity in fibrosing alveolitis. , 2003, American journal of respiratory and critical care medicine.
[36] J. Jamart,et al. Influence of radiological emphysema on lung function test in idiopathic pulmonary fibrosis. , 2013, Respiratory medicine.
[37] D. Hansell,et al. Lone cryptogenic fibrosing alveolitis: a functional-morphologic correlation based on extent of disease on thin-section computed tomography. , 1997, American journal of respiratory and critical care medicine.
[38] S. Ohlmeier,et al. Peroxiredoxin II Expression and Its Association With Oxidative Stress and Cell Proliferation in Human Idiopathic Pulmonary Fibrosis , 2008, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[39] S. Nathan,et al. Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant , 2007, European Respiratory Journal.
[40] Takeshi Johkoh,et al. American Thoracic Society Documents An Official ATS / ERS / JRS / ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management , 2011 .
[41] A. Azuma,et al. A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis , 2015 .
[42] K. P. Van de Woestijne,et al. Total respiratory resistance and reactance in patients with diffuse interstitial lung disease. , 1989, The European respiratory journal.
[43] Yoshitaka Tateishi,et al. Acidosis and raised norepinephrine levels are associated with exercise dyspnoea in idiopathic pulmonary fibrosis , 2009, Respirology.
[44] L. Fasano,et al. The presence of emphysema further impairs physiologic function in patients with idiopathic pulmonary fibrosis. , 2006, Respiratory care.
[45] J. Hughes,et al. Estimating exercise DLO2 and diffusion limitation in patients with interstitial fibrosis. , 1991, Respiration physiology.
[46] D. Hansell,et al. Functional and prognostic effects when emphysema complicates idiopathic pulmonary fibrosis , 2017, European Respiratory Journal.
[47] M. Terzano,et al. Sleep and respiratory sleep disorders in idiopathic pulmonary fibrosis. , 2016, Sleep medicine reviews.
[48] M. Sears. Predicting asthma outcomes. , 2015, The Journal of allergy and clinical immunology.
[49] Pedro Lopes de Melo,et al. Correlação dos achados tomográficos com parâmetros de função pulmonar na fibrose pulmonar idiopática em não fumantes* Correlation of tomographic findings with pulmonary function parameters in nonsmoking patients with idiopathic pulmonary fibrosis , 2007 .
[50] N. Isern,et al. Lactic acid is elevated in idiopathic pulmonary fibrosis and induces myofibroblast differentiation via pH-dependent activation of transforming growth factor-β. , 2012, American journal of respiratory and critical care medicine.
[51] A. Montgomery,et al. Ambulatory oxygen in interstitial lung disease , 2011, European Respiratory Journal.
[52] F. Martinez,et al. Lung function estimates in idiopathic pulmonary fibrosis: the potential for a simple classification , 2005, Thorax.
[53] I. Tillie‐Leblond,et al. Do We Need Exercise Tests to Detect Gas Exchange Impairment in Fibrotic Idiopathic Interstitial Pneumonias? , 2012, Pulmonary medicine.
[54] R. D. du Bois,et al. Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS(®) trials. , 2016, Respiratory medicine.
[55] A. Holland,et al. Greater endurance capacity and improved dyspnoea with acute oxygen supplementation in idiopathic pulmonary fibrosis patients without resting hypoxaemia , 2017, Respirology.
[56] A. Kotanidou,et al. The Role of Cardiopulmonary Exercise Test in IPF Prognosis , 2013, Pulmonary medicine.
[57] G. Oster,et al. Effect of Emphysema Extent on Serial Lung Function in Patients with Idiopathic Pulmonary Fibrosis , 2017, American journal of respiratory and critical care medicine.
[58] D. Streiner,et al. Assessing exertional dyspnea in patients with idiopathic pulmonary fibrosis. , 2014, Respiratory medicine.
[59] T. Perez,et al. Lung capillary blood volume and membrane diffusion in idiopathic interstitial pneumonia. , 2012, Respiratory medicine.
[60] W. Thurlbeck,et al. Correlation of structure and function in idiopathic pulmonary fibrosis. , 1995, American journal of respiratory and critical care medicine.
[61] L. Spencer,et al. Ambulatory oxygen in idiopathic pulmonary fibrosis: of what benefit? , 2012, European Respiratory Journal.
[62] J. Hankinson,et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung , 2005, European Respiratory Journal.
[63] S. Hashimoto,et al. [Assessment of pulmonary aerosol deposition and epithelial permeability in 99mTc-DTPA inhalation scintigram]. , 1993, Nihon Kyobu Shikkan Gakkai zasshi.
[64] M. Zorzetto,et al. A large kindred of pulmonary fibrosis associated with a novel ABCA3 gene variant , 2014, Respiratory Research.
[65] H. Collard,et al. The effect of bronchodilators on forced vital capacity measurement in patients with idiopathic pulmonary fibrosis. , 2015, Respiratory medicine.
[66] S. Harari,et al. Cellular interactions in the pathogenesis of interstitial lung diseases , 2015, European Respiratory Review.
[67] J. Barberà,et al. Effects of inhaled nitric oxide at rest and during exercise in idiopathic pulmonary fibrosis. , 2011, Journal of applied physiology.
[68] M. Cazzola,et al. Pirfenidone, nintedanib and N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis: A systematic review and meta-analysis. , 2016, Pulmonary pharmacology & therapeutics.
[69] K. Flaherty,et al. A Phase 2 Randomized Controlled Study of Tralokinumab in Subjects with Idiopathic Pulmonary Fibrosis , 2018, American journal of respiratory and critical care medicine.
[70] L. Voltolini,et al. Mortality on the Waiting List for Lung Transplantation in Patients with Idiopathic Pulmonary Fibrosis: A Single-Centre Experience , 2015, Lung.
[71] G. Raghu,et al. Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review , 2015, European Respiratory Journal.
[72] P. Revy,et al. Prevalence and characteristics of TERT and TERC mutations in suspected genetic pulmonary fibrosis , 2016, European Respiratory Journal.
[73] N. Cherniack,et al. Occlusion pressure and breathing pattern in patients with interstitial lung disease. , 2015, The American review of respiratory disease.
[74] Hui Liu,et al. Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis. , 2013, The Journal of clinical investigation.
[75] E. Rosenberg. The 1995 update of recommendations for a standard technique for measuring the single-breath carbon monoxide diffusing capacity (transfer factor) , 1996, American journal of respiratory and critical care medicine.
[76] B. Nemery,et al. Effect of alveolar volume on the interpretation of single breath DLCO. , 1997, Respiratory medicine.
[77] D. Schwartz,et al. The Idiopathic Pulmonary Fibrosis Honeycomb Cyst Contains A Mucocilary Pseudostratified Epithelium , 2013, PloS one.
[78] Joyce S Lee,et al. A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis , 2012, Annals of Internal Medicine.
[79] R. Wells,et al. Matrix biology of idiopathic pulmonary fibrosis: a workshop report of the national heart, lung, and blood institute. , 2014, The American journal of pathology.
[80] J D Fulmer,et al. Morphologic-physiologic correlates of the severity of fibrosis and degree of cellularity in idiopathic pulmonary fibrosis. , 1979, The Journal of clinical investigation.
[81] B. Porse,et al. Open Access Research , 2022 .
[82] A. Wanner,et al. Influence of lung inflation on the cross-sectional area of central airways in normals and in patients with lung disease. , 1981, Respiration; international review of thoracic diseases.
[83] R. Borie,et al. Familial forms of nonspecific interstitial pneumonia/idiopathic pulmonary fibrosis: clinical course and genetic background , 2012, Current opinion in pulmonary medicine.
[84] R. Eccles,et al. Mechanical induction of cough in Idiopathic Pulmonary Fibrosis , 2010, Cough.
[85] U. Demkow,et al. Angiogenic activity of sera from interstitial lung disease patients in relation to pulmonary function , 2010, European journal of medical research.
[86] H. Gin,et al. Nitrogen monoxide and carbon monoxide transfer interpretation: state of the art , 2017, Clinical physiology and functional imaging.
[87] Stefano Nava,et al. Lung and chest wall mechanics in ventilated patients with end stage idiopathic pulmonary fibrosis , 1999, Thorax.
[88] S. Leroy,et al. Fibrose pulmonaire idiopathique et shunt droit-gauche par foramen ovale perméable : amélioration clinique et gazométrique après fermeture percutanée , 2007 .
[89] Ivana V. Yang,et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. , 2011, The New England journal of medicine.
[90] J. Roca,et al. Different patterns of gas exchange response to exercise in asbestosis and idiopathic pulmonary fibrosis. , 1988, The European respiratory journal.
[91] H. Collard,et al. Pirfenidone Reduces Respiratory‐related Hospitalizations in Idiopathic Pulmonary Fibrosis , 2017, American journal of respiratory and critical care medicine.
[92] K. Snibson,et al. Structural and functional correlations in a large animal model of bleomycin-induced pulmonary fibrosis , 2015, BMC Pulmonary Medicine.
[93] K. Anstrom,et al. The UCSD shortness of breath questionnaire has longitudinal construct validity in idiopathic pulmonary fibrosis. , 2012, Respiratory medicine.
[94] F. Martinez,et al. CC-chemokine ligand 2 inhibition in idiopathic pulmonary fibrosis: a phase 2 trial of carlumab , 2015, European Respiratory Journal.
[95] J. Whitsett,et al. Ectopic respiratory epithelial cell differentiation in bronchiolised distal airspaces in idiopathic pulmonary fibrosis , 2011, Thorax.
[96] F. Martinez,et al. Pulmonary hypertension in idiopathic pulmonary fibrosis with mild-to-moderate restriction , 2015, European Respiratory Journal.
[97] F. Gigliotti,et al. Neural respiratory drive and neuromuscular coupling during CO2 rebreathing in patients with chronic interstitial lung disease. , 1989, Chest.
[98] L. Plantier,et al. Different KCO and VA combinations exist for the same DLCO value in patients with diffuse parenchymal lung diseases , 2015, BMC Pulmonary Medicine.
[99] H. Collard,et al. Comorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management , 2017, Front. Med..
[100] J. E. Hansen,et al. Cardiac output estimated noninvasively from oxygen uptake during exercise. , 1997, Journal of applied physiology.
[101] N. Strickland,et al. Cause of regional ventilation-perfusion mismatching in patients with idiopathic pulmonary fibrosis: a combined CT and scintigraphic study. , 1993, AJR. American journal of roentgenology.
[102] J E Cotes,et al. Lung volumes and forced ventilatory flows , 1993, European Respiratory Journal.
[103] R. D. du Bois,et al. Long-term course and prognosis of idiopathic pulmonary fibrosis in the new millennium. , 2011, Chest.
[104] R. Newton,et al. A study of the cough reflex in idiopathic pulmonary fibrosis. , 2003, American journal of respiratory and critical care medicine.
[105] Y. Kondoh,et al. Dyspnoea at 6-min walk test in idiopathic pulmonary fibrosis: comparison with COPD. , 2007, Respiratory medicine.
[106] J. Roca,et al. Clinical and functional assessment of patients with idiopathic pulmonary fibrosis: results of a 3 year follow-up. , 1994, The European respiratory journal.
[107] S. Harari,et al. Pulmonary hypertension in chronic interstitial lung diseases , 2013, European Respiratory Review.
[108] A. Nicholson,et al. Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. , 2003, American journal of respiratory and critical care medicine.
[109] G. Ferretti,et al. Diagnosis and management of idiopathic pulmonary fibrosis: French practical guidelines , 2014, European Respiratory Review.
[110] F. Martinez,et al. Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema , 2010, European Respiratory Journal.
[111] L. Farkas,et al. Angiogenesis in pulmonary fibrosis: too much or not enough? , 2012, Chest.
[112] J. Roca,et al. Mechanisms of gas-exchange impairment in idiopathic pulmonary fibrosis. , 1991, The American review of respiratory disease.
[113] H. Collard,et al. Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial. , 2017, The Lancet. Respiratory medicine.
[114] G. Raghu,et al. Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis. , 2010, American journal of respiratory and critical care medicine.
[115] S. Nathan,et al. Idiopathic pulmonary fibrosis and pulmonary hypertension: connecting the dots. , 2007, American journal of respiratory and critical care medicine.
[116] R. Hubbard,et al. The association between idiopathic pulmonary fibrosis and vascular disease: a population-based study. , 2008, American journal of respiratory and critical care medicine.
[117] W. Seeger,et al. Surfactant abnormalities in idiopathic pulmonary fibrosis, hypersensitivity pneumonitis and sarcoidosis. , 1999, The European respiratory journal.
[118] M. Mishima,et al. Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis. , 2007, Chest.
[119] Manuela Muratori,et al. Gas diffusion and alveolar-capillary unit in chronic heart failure. , 2006, European heart journal.
[120] M. Bran,et al. Respiratory drive and ventilatory pattern during exercise in interstitial lung disease. , 1981, Bulletin europeen de physiopathologie respiratoire.
[121] Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis. , 2015, The New England journal of medicine.
[122] S. Nathan,et al. Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis. , 2007, Chest.
[123] J. Curtis,et al. The sensitivity of high-resolution CT in detecting idiopathic pulmonary fibrosis proved by open lung biopsy. A prospective study. , 1995, Chest.
[124] 長尾 光修. The Lung: Scientific Foundations , 1997 .
[125] A. Wells,et al. Pulmonary vascular limitation to exercise and survival in idiopathic pulmonary fibrosis , 2014, Respirology.
[126] K. Wasserman,et al. Exercise capacity in idiopathic pulmonary fibrosis: The effect of pulmonary hypertension , 2011, Respirology.
[127] D. Schwartz,et al. The MUC5B Variant Is Associated with Idiopathic Pulmonary Fibrosis but Not with Systemic Sclerosis Interstitial Lung Disease in the European Caucasian Population , 2013, PloS one.
[128] J. Heyder,et al. Aerosol-derived airway morphometry and aerosol bolus dispersion in patients with lung fibrosis and lung emphysema. , 1999, Chest.
[129] Y. Castier,et al. Pulmonary vascular lesions in end-stage idiopathic pulmonary fibrosis: Histopathologic study on lung explant specimens and correlations with pulmonary hemodynamics. , 2007, Human pathology.
[130] D. Jastrzębski,et al. [Pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis with inspiratory muscle training]. , 2008, Pneumonologia i alergologia polska.
[131] L. Plantier,et al. Increased volume of conducting airways in idiopathic pulmonary fibrosis is independent of disease severity: a volumetric capnography study , 2016, Journal of breath research.
[132] Takashi Suzuki,et al. Heterogeneous increase in CD34-positive alveolar capillaries in idiopathic pulmonary fibrosis. , 2004, American journal of respiratory and critical care medicine.
[133] J. Jeudy,et al. Variable prevalence of pulmonary hypertension in patients with advanced interstitial pneumonia. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[134] Rohan S. Virgincar,et al. Using hyperpolarized 129Xe MRI to quantify regional gas transfer in idiopathic pulmonary fibrosis , 2017, Thorax.
[135] W. Galetke,et al. Reference values for dynamic and static pulmonary compliance in men. , 2007, Respiratory medicine.
[136] Meilan K. Han,et al. Predicting pulmonary fibrosis disease course from past trends in pulmonary function. , 2014, Chest.
[137] S. Sahn,et al. Forced vital capacity in patients with idiopathic pulmonary fibrosis: test properties and minimal clinically important difference. , 2011, American journal of respiratory and critical care medicine.
[138] P. Paré,et al. Correlation between pulmonary fibrosis and the lung pressure-volume curve , 2004, Lung.